Today: 7 February 2026
Subscribe
Browse Category

Financial Forecasts News 3 December 2025 - 4 December 2025

WiseTech Global (ASX:WTC) Share Price Jumps on Investor Day and RBC Upgrade: 2026 Outlook, Risks and Forecasts

WiseTech Global (ASX:WTC) Share Price Jumps on Investor Day and RBC Upgrade: 2026 Outlook, Risks and Forecasts

Sydney – 4 December 2025 WiseTech Global Ltd (ASX:WTC) has lurched from market darling to governance lightning rod in 2025, but the past week has finally delivered some good news for bruised shareholders. The logistics software giant’s share price has bounced off its recent lows as investors digest a major shift in its commercial model, a transformative US acquisition, and a fresh vote of confidence from RBC Capital. At the same time, an ongoing insider‑trading probe, earlier governance crises and a heavy new debt load mean the stock still carries substantial risk. Below is a detailed look at where WiseTech
4 December 2025
·····
Mastercard Stock (MA) Today: AI Payments, Analyst Price Targets and 2026 Outlook – December 3, 2025

Mastercard Stock (MA) Today: AI Payments, Analyst Price Targets and 2026 Outlook – December 3, 2025

Published: December 3, 2025 – Information only, not investment advice. Mastercard stock on 3 December 2025: price and market snapshot As of the close on December 3, 2025, Mastercard Incorporated (NYSE: MA) is trading around $553.73 per share, modestly higher on the day and roughly mid‑range in its 52‑week band. Recent filings and price data show: Mastercard also pays a quarterly dividend of $0.76 per share (annualized $3.04, yield close to 0.6%) with a payout ratio under 20%, leaving plenty of room to reinvest in growth while still returning cash to shareholders. MarketBeat Institutional ownership remains extremely high at roughly
3 December 2025
····
Pfizer Stock (PFE) Today – Price, Metsera Obesity Bet, RSV Vaccine Tailwinds and 2026 Forecast (3 December 2025)

Pfizer Stock (PFE) Today – Price, Metsera Obesity Bet, RSV Vaccine Tailwinds and 2026 Forecast (3 December 2025)

Pfizer Inc. (NYSE: PFE) remains one of the most closely watched healthcare stocks as of December 3, 2025. The share price is still stuck near post‑COVID lows, but a new $10 billion obesity‑drug acquisition, expanding RSV vaccine markets and a hefty dividend yield around 6.5–7% are reshaping the narrative around the stock. Pfizer+2Pfizer+2 Below is a deep dive into where Pfizer stock stands today, which headlines are moving it, and how Wall Street currently values PFE for 2026 and beyond. 1. Pfizer stock today: price, trading range and valuation As of late trading on December 3, 2025, Pfizer shares are
3 December 2025
···
Bloom Energy (BE) Stock on December 3, 2025: Price, Forecast, and AI Data Center Boom Risks

Bloom Energy (BE) Stock on December 3, 2025: Price, Forecast, and AI Data Center Boom Risks

Updated: December 3, 2025 — Informational article, not investment advice. Bloom Energy Corporation (NYSE: BE) has turned into one of 2025’s most explosive AI‑infrastructure trades. After a year of breathtaking gains fueled by artificial intelligence data‑center demand, the stock is now at the center of an intense debate: is Bloom Energy an AI power winner still in the early innings, or a momentum bubble stretched far beyond its fundamentals? This deep dive pulls together the latest price action, news, forecasts, and analyst views as of December 3, 2025, to help you understand what’s really driving Bloom Energy stock today. 1.
3 December 2025
·····
Vanguard’s Grim 10‑Year Forecast Puts the 4% Retirement Rule at Risk — What Retirees Should Do Now

Vanguard’s Grim 10‑Year Forecast Puts the 4% Retirement Rule at Risk — What Retirees Should Do Now

Published: December 3, 2025 If you retired planning to “just follow the 4% rule,” today’s headlines should make you sit up. Vanguard’s latest capital markets outlook projects that U.S. stocks may return only about 2.8%–4.8% a year over the next decade, while high‑quality bonds are expected to earn around 4.3%–5.3% annually. PR Newswire+1 At the same time, a MarketWatch column published this morning warns that a “lost decade” of low stock returns could be devastating for retirees who keep withdrawing a fixed 4% a year regardless of market conditions. MarketWatch+1 Layer on the demographic reality: about 11,400 Americans are turning 65 every single day in 2025,
3 December 2025
···
Astera Labs (ALAB) Stock Rebounds After NVLink Fusion Shock: December 3, 2025 News, Forecasts and AI Outlook

Astera Labs (ALAB) Stock Rebounds After NVLink Fusion Shock: December 3, 2025 News, Forecasts and AI Outlook

Astera Labs, Inc. (NASDAQ: ALAB) is back in focus on December 3, 2025, after a dramatic two‑day swing that combined a double‑digit sell‑off, a new NVLink Fusion connectivity announcement with NVIDIA, and a wave of fresh analyst commentary. As of late trading on Wednesday, Astera Labs stock changes hands around $151 per share, up roughly 6% on the day, with an intraday range between about $145 and $154. That bounce comes after a 13% drop on December 2, when the stock slid from roughly $165 to $143 amid investor anxiety over Amazon’s new AI partnership with NVIDIA.TS2 Tech+1 Below is
3 December 2025
·····
JPMorgan Chase (JPM) Stock Today: Near Record Highs, Q3 2025 Earnings Beat and 2026 Analyst Forecasts (3 December 2025)

JPMorgan Chase (JPM) Stock Today: Near Record Highs, Q3 2025 Earnings Beat and 2026 Analyst Forecasts (3 December 2025)

JPMorgan Chase & Co. (NYSE: JPM) continues to trade close to record levels as investors digest robust third‑quarter 2025 results, a massive $50 billion buyback program and a series of regulatory and macro headlines that could shape returns into 2026. As of December 3, 2025, JPMorgan’s share price hovers around $311 per share, after closing at $311.41 on Wednesday’s session.StockAnalysis This article summarizes all the key news, forecasts and analyses currently available as of 3 December 2025, and is intended for informational purposes only—not as personalized investment advice. 1. JPMorgan Chase stock snapshot as of December 3, 2025 Price and
3 December 2025
····
Applied Materials (AMAT) Stock Hits Record Highs on AI Chip Boom – Latest News, Analyst Targets and Forecasts as of December 3, 2025

Applied Materials (AMAT) Stock Hits Record Highs on AI Chip Boom – Latest News, Analyst Targets and Forecasts as of December 3, 2025

Applied Materials, Inc. (NASDAQ: AMAT) is trading around all‑time highs in early December 2025 as investors pile into “picks and shovels” plays on the artificial intelligence (AI) chip boom. The stock has surged more than 60% year to date and briefly touched a record level near $267 per share, even as new U.S. export controls on China and rich valuations spark warnings of a potential pullback. Investing.com Nigeria+1 Below is a detailed, Google‑News‑friendly rundown of today’s news, forecasts and analyses on AMAT stock as of December 3, 2025. Key facts about AMAT stock on December 3, 2025 Why AMAT is
3 December 2025
····
Circle Internet Group (CRCL) Stock Outlook on December 3, 2025: Price Action, Analyst Ratings and 2026 Forecast

Circle Internet Group (CRCL) Stock Outlook on December 3, 2025: Price Action, Analyst Ratings and 2026 Forecast

1. Snapshot: Where Circle Internet Group Stock Stands Today Circle Internet Group, Inc. (NYSE: CRCL), the issuer of USD Coin (USDC) and EURC, remains one of 2025’s most volatile post‑IPO names. As of the close on December 3, 2025, CRCL finished at $84.14, up 8.65% on the day, after trading between $76.02 and $85.23 on volume of about 14.6 million shares. Over the last month it has rebounded from late‑November lows in the low‑$70s.Investing.com Despite the latest bounce, CRCL is still dramatically below its summer peak. The stock’s 52‑week range runs from $64.00 to $298.99, underlining just how violent the
3 December 2025
·····
CoreWeave (CRWV) Stock After a 45% November Crash: Latest News, Analyst Forecasts and AI Cloud Outlook as of December 3, 2025

CoreWeave (CRWV) Stock After a 45% November Crash: Latest News, Analyst Forecasts and AI Cloud Outlook as of December 3, 2025

CoreWeave, Inc. (NASDAQ: CRWV) has become one of the most closely watched AI infrastructure stocks in 2025. After a spectacular run following its March IPO, the Nvidia‑backed GPU cloud provider is now grappling with a brutal drawdown, mounting debt, and growing debate over whether its valuation still makes sense. As of late trading on December 3, 2025, CoreWeave shares trade around the mid‑$70s (roughly $77, up about 1–2% on the day), well above the $40 IPO price but roughly 60% below their late‑June peak near $187. Yahoo Finance+1 Below is a detailed, SEO‑focused look at CoreWeave stock today – including
3 December 2025
····
Capricor Therapeutics (CAPR) Stock Skyrockets on HOPE‑3 Win: FDA Path, Price Targets and 2026 Outlook

Capricor Therapeutics (CAPR) Stock Skyrockets on HOPE‑3 Win: FDA Path, Price Targets and 2026 Outlook

Updated December 3, 2025 Capricor Therapeutics, Inc. (NASDAQ: CAPR) has just turned into one of the wildest biotech stories of 2025. After the company reported positive topline results from its pivotal Phase 3 HOPE‑3 trial of deramiocel in Duchenne muscular dystrophy (DMD) early Wednesday, CAPR stock exploded from roughly $6.36 at Tuesday’s close to around $30 in Wednesday’s trading — a move of about +380%, with intraday highs near $40 and gains at one point exceeding +500%. BioPharma Dive At the same time, Wall Street analysts, regulators and patient advocates are rapidly reassessing both the approval odds and the long‑term
3 December 2025
····
BitMine Immersion Technologies (BMNR) Stock Today: Ex‑Dividend Surge, 3.73M ETH Bet and 2026–2030 Forecasts (3 December 2025)

BitMine Immersion Technologies (BMNR) Stock Today: Ex‑Dividend Surge, 3.73M ETH Bet and 2026–2030 Forecasts (3 December 2025)

As of 3 December 2025, BitMine Immersion Technologies, Inc. (NYSE American: BMNR) is one of the most talked‑about crypto‑linked stocks on the market. The shares are trading in the low‑$30s after another double‑digit swing, investors are positioning ahead of an upcoming dividend, and the company has confirmed a record 3.73 million ETH on its balance sheet – over 3% of the Ethereum supply. Morningstar+2Insider Monkey+2 This article pulls together the latest news, forecasts and analyses as of December 3, 2025, to help readers understand what’s really driving BMNR stock and what risks come with this extremely volatile Ethereum treasury play.
3 December 2025
·····
1 … 54 55 56 57 58 … 68

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Go toTop